Benzinga.com

What's Going On With Revvity Stock Today?

Revvity, Inc. (NYSE:RVTY) shares are trading higher on Wednesday. The company announced today that the U.S. Food and Drug Administration has approved its Auto-Pure 2400 liquid handling platform, ...
Seeking Alpha

Revvity Secures FDA Approval for Improved Automated Latent Tuberculosis Test

FDA approves leading solution for latent tuberculosis diagnostics, advancing global effort to fight infectious diseases “The integration of the Auto-Pure 2400 platform with the T-SPOT.TB test gives ...
Hosted on MSN

FDA approves Revvity’s Auto-Pure platform and tuberculosis test combo

The US Food and Drug Administration (FDA) has granted approval for Revvity’s Auto-Pure 2400 liquid handling platform, used in conjunction with the T-SPOT.TB test. This approval introduces an ...
EurekAlert!

Recombinant fusion ESAT6-CFP10 immunogen as a skin test reagent for tuberculosis diagnosis in children and adolescents: An open-label, randomized, multicenter phase III trial

Flowchart of all participants. TB: tuberculosis; T-SPOT.TB: interferon-gamma release assay; TST: tuberculin skin test; C-TST: creation tuberculin skin test; PTB: pulmonary tuberculosis; EPTB: ...
Nasdaq

Revvity Gets FDA Approval For Automated Latent Tuberculosis Test

(RTTNews) - Revvity, Inc. (RVTY), Wednesday said that the U.S. Food and Drug Administration (FDA) has approved the Auto-Pure 2400 liquid handling platform with the T-SPOT. tuberculosis (TB) test. "The ...